Effectiveness of a long‐acting injectable form of bromocriptine in patients with prolactin and growth hormone secreting macroadenomas (Q71956093)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7634499%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

title

Effectiveness of a long-acting injectable form of bromocriptine in patients with prolactin and growth hormone secreting macroadenomas (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7634499%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

Effectiveness of a long‐acting injectable form of bromocriptine in patients with prolactin and growth hormone secreting macroadenomas (English)

1 reference

https://api.crossref.org/works/10.1111/J.1365-2265.1995.TB02685.X

25 June 2024

author name string

S. Tsagarakis

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7634499

25 June 2024

E. Tsiganou

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7634499

25 June 2024

I. Tzavara

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7634499

25 June 2024

H. Nikolou

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7634499

25 June 2024

N. Thalassinos

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7634499

25 June 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=7634499

25 June 2024

publication date

1 June 1995

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7634499%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

22 October 2019

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1365-2265.1995.tb02685.x

1 reference

https://api.crossref.org/works/10.1111/J.1365-2265.1995.TB02685.X

https://onlinelibrary.wiley.com/doi/pdf/10.1111/j.1365-2265.1995.tb02685.x

25 June 2024

1 reference

https://api.crossref.org/works/10.1111/J.1365-2265.1995.TB02685.X

25 June 2024

published in

Clinical Endocrinology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7634499%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

volume

42

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7634499%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7634499%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

page(s)

593-599

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7634499%20AND%20SRC:MED&resulttype=core&format=json

Treatment of macroprolactinomas with the long-acting and repeatable form of bromocriptine: a report on 29 cases

22 October 2019

cites work

1

1 reference

https://api.crossref.org/works/10.1111/J.1365-2265.1995.TB02685.X

Dopamine agonists and pituitary tumor shrinkage

25 June 2024

2

1 reference

https://api.crossref.org/works/10.1111/J.1365-2265.1995.TB02685.X

Double blind randomized study using oral or injectable bromocriptine in patients with hyperprolactinaemia

25 June 2024

4

1 reference

https://api.crossref.org/works/10.1111/J.1365-2265.1995.TB02685.X

Long-term treatment with a new repeatable injectable form of bromocriptine, Parlodel LAR, in patients with tumorous hyperprolactinemia

25 June 2024

5

1 reference

https://api.crossref.org/works/10.1111/J.1365-2265.1995.TB02685.X

25 June 2024

Prolactinomas

7

1 reference

https://api.crossref.org/works/10.1111/J.1365-2265.1995.TB02685.X

Depot-bromocriptine treatment for prolactinomas and acromegaly

25 June 2024

8

1 reference

https://api.crossref.org/works/10.1111/J.1365-2265.1995.TB02685.X

Control of prolactin-secreting macroadenomas with parenteral, long-acting bromocriptine in 30 patients treated for up to 3 years

25 June 2024

10

1 reference

https://api.crossref.org/works/10.1111/J.1365-2265.1995.TB02685.X

Rapid and long-lasting suppression of prolactin secretion and shrinkage of prolactinomas after injection of long-acting repeatable form of bromocriptine (Parlodel LAR)

25 June 2024

13

1 reference

https://api.crossref.org/works/10.1111/J.1365-2265.1995.TB02685.X

Resistance to bromocriptine in prolactinomas

25 June 2024

14

1 reference

https://api.crossref.org/works/10.1111/J.1365-2265.1995.TB02685.X

Evaluation of a repeatable depot-bromocriptine preparation(Parlodel LAR) for the treatment of acromegaly.

25 June 2024

15

1 reference

https://api.crossref.org/works/10.1111/J.1365-2265.1995.TB02685.X

Drugs five years later. Bromocriptine

25 June 2024

16

1 reference

https://api.crossref.org/works/10.1111/J.1365-2265.1995.TB02685.X

Reduction of pituitary-tumour size in patients with prolactinomas and acromegaly treated with bromocriptine with or without radiotherapy

25 June 2024

18

1 reference

https://api.crossref.org/works/10.1111/J.1365-2265.1995.TB02685.X

25 June 2024

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7634499%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

1 reference